K. Fujimoto

1.5k total citations
50 papers, 1.3k citations indexed

About

K. Fujimoto is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Endocrine and Autonomic Systems. According to data from OpenAlex, K. Fujimoto has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Molecular Biology and 9 papers in Endocrine and Autonomic Systems. Recurrent topics in K. Fujimoto's work include Diabetes Treatment and Management (8 papers), Mast cells and histamine (6 papers) and Diet and metabolism studies (5 papers). K. Fujimoto is often cited by papers focused on Diabetes Treatment and Management (8 papers), Mast cells and histamine (6 papers) and Diet and metabolism studies (5 papers). K. Fujimoto collaborates with scholars based in Japan, United States and Australia. K. Fujimoto's co-authors include Takeshi Sakata, Patrick Tso, Koji Fukagawa, James A. Cardelli, Hidehiko Yoshimatsu, Kazuyoshi Ookuma, Hiroshi Wada, Hiroshi Hayashi, P. Tso and David F. Nutting and has published in prestigious journals such as Journal of Clinical Investigation, Brain Research and Biochemical and Biophysical Research Communications.

In The Last Decade

K. Fujimoto

46 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Fujimoto Japan 18 415 388 330 323 316 50 1.3k
Yong Gao China 19 382 0.9× 356 0.9× 134 0.4× 147 0.5× 61 0.2× 32 1.0k
B Filippi Canada 21 935 2.3× 276 0.7× 360 1.1× 308 1.0× 56 0.2× 44 1.7k
Kirill Essin Germany 17 729 1.8× 76 0.2× 296 0.9× 77 0.2× 95 0.3× 19 1.8k
Garron T. Dodd Australia 22 596 1.4× 623 1.6× 190 0.6× 189 0.6× 234 0.7× 32 1.9k
Mangala M. Soundarapandian United States 15 888 2.1× 85 0.2× 109 0.3× 93 0.3× 97 0.3× 18 1.5k
Lionel Carneiro France 19 399 1.0× 225 0.6× 270 0.8× 248 0.8× 32 0.1× 31 1.1k
Alexander M. Efanov Sweden 23 1.2k 2.9× 79 0.2× 1.1k 3.2× 469 1.5× 54 0.2× 40 2.0k
Leslie E. Landree United States 13 985 2.4× 375 1.0× 368 1.1× 138 0.4× 45 0.1× 13 1.7k
C. Hofmann United States 17 705 1.7× 95 0.2× 211 0.6× 255 0.8× 68 0.2× 24 1.3k
Walter S. Zawalich United States 31 1.4k 3.3× 222 0.6× 2.0k 6.0× 1.2k 3.8× 63 0.2× 71 2.8k

Countries citing papers authored by K. Fujimoto

Since Specialization
Citations

This map shows the geographic impact of K. Fujimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Fujimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Fujimoto more than expected).

Fields of papers citing papers by K. Fujimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Fujimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Fujimoto. The network helps show where K. Fujimoto may publish in the future.

Co-authorship network of co-authors of K. Fujimoto

This figure shows the co-authorship network connecting the top 25 collaborators of K. Fujimoto. A scholar is included among the top collaborators of K. Fujimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Fujimoto. K. Fujimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hataya, Yuji, et al.. (2025). Bilateral adrenal infarction in a patient with essential thrombocythemia: a case report and brief literature review. Oxford Medical Case Reports. 2025(8). omaf129–omaf129.
2.
Hataya, Yuji, et al.. (2024). Development of Chronic Thyroiditis During Cyclosporin A Treatment. JCEM Case Reports. 2(12). luae211–luae211. 1 indexed citations
3.
Hataya, Yuji, et al.. (2024). Correlation Between Glycemic Control and Serum Thyroglobulin Levels in a Patient With RAI-Refractory Thyroid Cancer. JCEM Case Reports. 2(5). luae085–luae085. 1 indexed citations
7.
Hamamoto, Yoshiyuki, Sachiko Honjo, K. Fujimoto, et al.. (2017). Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 Diabetes Mellitus: A Pilot Study. Clinical Drug Investigation. 37(9). 845–852. 4 indexed citations
8.
Aikata, Hiroshi, Kazuaki Chayama, Kento Imajo, et al.. (2014). Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients Takashi NakaharaHideyuki HyogoMasato YonedaYoshio SumidaYuichiro EguchiHideki Fujii • Masafumi OnoTakumi KawaguchiKento ImajoHiroshi AikataSaiyu TanakaKazuyuki Kanemasa • Kazuma FujimotoKeizo AnzaiToshiji SaibaraMichio SataAtushi NakajimaYoshito Itoh • Kazuaki ChayamaTakeshi OkanoueJapan Study Group of Nonalcoholic Fatty Liver …. 3 indexed citations
9.
Tatsuoka, Hisato, Sachiko Honjo, Yoshiyuki Hamamoto, et al.. (2012). Primary aldosteronism associated with subclinical Cushing syndrome. 15th International & 14th European Congress of Endocrinology. 29. 21 indexed citations
10.
Hamamoto, Yoshiyuki, Sachiko Honjo, Yukiko Kawasaki, et al.. (2012). Relationship between Telmisartan Dose and Glycaemic Control in Japanese Patients with Type 2 Diabetes Mellitus and Hypertension. Clinical Drug Investigation. 32(9). 577–582. 2 indexed citations
11.
Hamamoto, Yoshiyuki, Sachiko Honjo, Yukiko Kawasaki, et al.. (2012). Relationship between Telmisartan Dose and Glycaemic Control in Japanese Patients with Type 2 Diabetes Mellitus and Hypertension. Clinical Drug Investigation. 32(9). 577–582. 1 indexed citations
12.
Ohkusa, Toshifumi�, T Maekawa, T. Arakawa, et al.. (2005). Effect of CYP2C19 polymorphism on the safety and efficacy of omeprazole in Japanese patients with recurrent reflux oesophagitis. Alimentary Pharmacology & Therapeutics. 21(11). 1331–1339. 19 indexed citations
13.
Ogata, Sho, et al.. (1997). Effect of Polydextrose on Absorption of Triglyceride and Cholesterol in Mesenteric Lymph-Fistula Rats. Experimental Biology and Medicine. 215(1). 53–58. 11 indexed citations
14.
Horio, Yoshiyuki, et al.. (1994). Does the [3H]mepyramine binding site represent the histamine H1 receptor? Re-examination of the histamine H1 receptor with quinine.. Journal of Pharmacology and Experimental Therapeutics. 268(2). 959–964. 14 indexed citations
15.
Fujimoto, K., Ikuo Imamura, D. Neil Granger, et al.. (1992). Histamine and histidine decarboxylase are correlated with mucosal repair in rat small intestine after ischemia-reperfusion.. Journal of Clinical Investigation. 89(1). 126–133. 46 indexed citations
16.
Sakata, Takeshi, Koji Fukagawa, Kazuyoshi Ookuma, et al.. (1990). Hypothalamic neuronal histamine modulates ad libitum feeding by rats. Brain Research. 537(1-2). 303–306. 62 indexed citations
17.
Fujimoto, K., Takeshi Sakata, Kazuyoshi Ookuma, et al.. (1990). Hypothalamic histamine modulates adaptive behavior of rats at high environmental temperature. Cellular and Molecular Life Sciences. 46(3). 283–285. 39 indexed citations
18.
Okabe, Yasuhiro, et al.. (1988). Differential Mechanisms of Feeding Modulation Induced by Amino Sugars in Rats. Experimental Biology and Medicine. 188(1). 23–29. 8 indexed citations
19.
Sakata, Takeshi, Koji Fukagawa, K. Fujimoto, et al.. (1988). Feeding induced by blockade of histamine H1-receptor in rat brain. Cellular and Molecular Life Sciences. 44(3). 216–218. 67 indexed citations
20.
Fujimoto, K., Takemasa Sakaguchi, & M Ui. (1981). Adrenergic mechanisms in the hyperglycaemia and hyperinsulinaemia of diabetic KK mice. Diabetologia. 20(5). 568–72. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026